Back to Agenda
Scientific Communication Key Message Development, Management, and Dissemination
Session Chair(s)
David B. Clemow, PHD
Advisor, Scientific Communications Information Strategy, Eli Lilly and Company, United States
This session will provide solutions for optimizing key message development and disclosure, including input/output links, data-to-message mapping, and awareness/access details important for strategic alignment of scientific narrative.
Learning Objective : Share scientific key message and narrative development, management, and disclosure processes; Define the cross-functional inputs and outputs of medical/scientific key message development, including the role of advisory board relationships and workshops in message development; Summarize improved and expanded awareness to key messages, including new methods to communicate complex medical information to maximize their value.
Speaker(s)
David B. Clemow, PHD
Advisor, Scientific Communications Information Strategy, Eli Lilly and Company, United States
Kristine Jolliffe
Director, Scientific Content, Six Degrees Medical Consulting, Canada
Wesley Winston Portegies, MBA
Chief Strategy Officer & Founder, Medcomms Experts, United States
Have an account?